Literature DB >> 28410118

Disparity in rates of HPV infection and cervical cancer in underserved US populations.

Asok Ranjan Karuri1, Vivek Kumar Kashyap1, Murali Mohan Yallapu1, Nadeem Zafar2, Satish K Kedia3, Meena Jaggi1, Subhash C Chauhan4.   

Abstract

There is a higher rate of HPV infection and cervical cancer incidence and mortality in underserved US population who reside in Appalachian mountain region compared to Northern Plains. Social and behavioral factors such as smoking and alcohol consumption are for such a high incidence. However, by and large, the reasons for these discrepancies lie in the reluctance of the underserved population to adopt preventive measures such as prophylactic Human papilloma virus (HPV) vaccines and Pap smear screening that have significantly reduced the incidence and mortality rate of cervical cancer in Caucasian women. Thus, it is clear that drastic change in social behavior and implementation of preventive measures is required to effectively reduce the incidence and mortality from cervical cancer in this underserved population.

Entities:  

Mesh:

Year:  2017        PMID: 28410118      PMCID: PMC5935458          DOI: 10.2741/s486

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  47 in total

Review 1.  The disparity of cervical cancer in diverse populations.

Authors:  Levi S Downs; Jennifer S Smith; Isabel Scarinci; Lisa Flowers; Groesbeck Parham
Journal:  Gynecol Oncol       Date:  2008-05       Impact factor: 5.482

2.  C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer--an in silico approach.

Authors:  G Reshmi; Ramachandran Surya; V T Jissa; P S Saneesh Babu; N R Preethi; W S Santhi; P G Jayaprakash; M Radhakrishna Pillai
Journal:  Genomics       Date:  2011-06-17       Impact factor: 5.736

3.  Perceptions of cancer controllability and cancer risk knowledge: the moderating role of race, ethnicity, and acculturation.

Authors:  A Susana Ramírez; Lila J Finney Rutten; April Oh; Bryan Leyva Vengoechea; Richard P Moser; Robin C Vanderpool; Bradford W Hesse
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

4.  Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium.

Authors:  Loris Y Hwang; Mark E Scott; Yifei Ma; Anna-Barbara Moscicki
Journal:  J Reprod Immunol       Date:  2010-11-03       Impact factor: 4.054

5.  Association of interleukin-6 in women with persistence of DNA-HPV: a nested case-control study.

Authors:  Maria Inês Rosa; Matheus Villas Moraes; Francieli Vuolo; Fabricia Petronilho; Mary Clarisse Bozzetti; Lidia Rosi Medeiros; Cristine Nascente Igansi; Fábio Rosa Silva; Felipe Dal-Pizzol; Daniela Dorneles Rosa
Journal:  Arch Gynecol Obstet       Date:  2011-05-25       Impact factor: 2.344

6.  Perceived risk of cervical cancer in Appalachian women.

Authors:  Kimberly M Kelly; Amy K Ferketich; Mack T Ruffin Iv; Cathy Tatum; Electra D Paskett
Journal:  Am J Health Behav       Date:  2012-11

7.  Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies.

Authors:  Kelly D Blake; Allison J Ottenbacher; Lila J Finney Rutten; Meredith A Grady; Sarah C Kobrin; Robert M Jacobson; Bradford W Hesse
Journal:  Am J Prev Med       Date:  2015-02-18       Impact factor: 5.043

8.  HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.

Authors:  Susan Hariri; Elizabeth R Unger; Sean Schafer; Linda M Niccolai; Ina U Park; Karen C Bloch; Nancy M Bennett; Martin Steinau; Michelle L Johnson; Lauri E Markowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-21       Impact factor: 4.254

9.  Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa.

Authors:  Subhash C Chauhan; Meena Jaggi; Maria C Bell; Mukesh Verma; Deepak Kumar
Journal:  Methods Mol Biol       Date:  2009

10.  Measuring cervical cancer risk: development and validation of the CARE Risky Sexual Behavior Index.

Authors:  Paul L Reiter; Mira L Katz; Amy K Ferketich; Mack T Ruffin; Electra D Paskett
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

View more
  3 in total

1.  VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.

Authors:  Vivek K Kashyap; Nirnoy Dan; Neeraj Chauhan; Qinghui Wang; Saini Setua; Prashanth K B Nagesh; Shabnam Malik; Vivek Batra; Murali M Yallapu; Duane D Miller; Wei Li; Bilal B Hafeez; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Lett       Date:  2019-12-03       Impact factor: 9.756

2.  Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database.

Authors:  Guo Feng; Zhang Beilei; Chen Caizhi; Zou Wen
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

Review 3.  Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer.

Authors:  Deepak Parashar; Anupam Singh; Saurabh Gupta; Aishwarya Sharma; Manish K Sharma; Kuldeep K Roy; Subhash C Chauhan; Vivek K Kashyap
Journal:  Genes (Basel)       Date:  2022-07-15       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.